Glycopyrrolate 1mg tablets are prescribed to be taken three times a day to reduce excessive drooling or treat peptic ulcers. It works by blocking acetylcholine to decrease stomach acid secretion and saliva production. Common side effects include dry mouth, skin, and nose. Nurses should monitor heart rate when administering and instruct patients to take it before meals.
Glycopyrrolate 1mg tablets are prescribed to be taken three times a day to reduce excessive drooling or treat peptic ulcers. It works by blocking acetylcholine to decrease stomach acid secretion and saliva production. Common side effects include dry mouth, skin, and nose. Nurses should monitor heart rate when administering and instruct patients to take it before meals.
Glycopyrrolate 1mg tablets are prescribed to be taken three times a day to reduce excessive drooling or treat peptic ulcers. It works by blocking acetylcholine to decrease stomach acid secretion and saliva production. Common side effects include dry mouth, skin, and nose. Nurses should monitor heart rate when administering and instruct patients to take it before meals.
MODE OF ACTION: Glycopyrrolate tablets are an anticholinergic. It works by blocking the activity of a certain substance (acetylcholine) in the body, which decreases stomach acid secretion. Adjunct in treatment of peptic ulcer disease; inhibit salivation and excessive secretions of the respiratory tract preoperatively; reversal of neuromuscular blockade; control of upper airway secretions INDICATION: - to reduce excessive drooling caused by medical conditions (such as cerebral palsy) - to treat peptic ulcers in combination with other medicines. CONTRAINDICATION: Narrow-angle glaucoma, acute hemorrhage, tachycardia, hypersensitivity to glycopyrrolate or any component; ulcerative colitis, obstructive uropathy, paralytic ileus, obstructive disease of GI tract SIDE EFFECTS: ADVERSE EFFECTS: dry skin, dry throat, constipation, xerostomia, dry nose, increased sensitivity to light, dysphagia DRUG INTERACTION: Solid oral potassium products (eg, tablets) because the risk of stomach or bowel irritation may be increased by glycopyrrolate tablets